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Figure S1. Typical electropherogram showing a segment of diagnostic base-calling DNA-sequence of 
a 357-bp M1/M2 second PCR amplicon, sequenced with M2 primer, showing the underlined TTTTAG 
sequence complex characteristic of a B. burgdorferi 16S rRNA gene immediately downstream of the M1 
primer binding site on the blood sample from a patient living in the United States. The underlined base 
“G” at position 54 indicates that this is not a B. garinii Bernie strain (See Figure 1, Sequence #2) 
 
  
Figure S2. Reverse M1 primer sequencing of the 357-bp M1/M2 second PCR amplicon used to generate 
the DNA sequence in Figure S1, showing an underlined base “G” at position 201, indicating that this was 
a 16S rRNA gene sequence of B. burgdorferi, not B. afzelii (see Figure 1, Sequence #3, to read reverse 
complement). An underlined “C” at position 38 indicates that this was not a sequence of B. garinii Bernie 
strain. Based on single nucleotide polymorphisms, the less common B. spielmanii and B. carolinensis are also 
excluded.  (see Figure 1, Sequences #2, #4 and #8 to read reverse complement). 
 
 
 
 
 
 
 
Figure S3. Typical sequence segment of the M1/M2 primer second PCR amplicon for molecular 
diagnosis of B. garinii Bernie strain in a tick collected in Portumna, Galway County, Ireland, using M2 
sequencing primer (note the underlined base “A” at position 54, compared with the corresponding base 
“G” at position 54 in Figure S1 for B. burgdorferi) 
 
 
Figure S4. Typical sequence segment of the M1/M2 primer second PCR amplicon for molecular 
diagnosis of B. garinii Bernie strain in a tick collected in Portumna, Galway County, Ireland, using M1 as 
the sequencing primer (note the underlined base “T” at position 31, compared with the corresponding 
underlined base “C” at position 38 in Figure S2 for B. burgdorferi)                                                             
 
  
Figure S5. Typical segment of a diagnostic base-calling DNA-sequencing electropherogram from a 
357-bp PCR amplicon, sequenced with M2 primer, showing the underlined TTTCAG sequence complex 
characteristic of B. valaisiana 16S rRNA gene immediately downstream of the M1 primer binding site (see 
Figure 1, Sequence #5) This sample was from a tick collected in Killarney, Kerry County, Ireland.  
 
 Figure S6. Typical segment of a diagnostic base-calling DNA-sequencing electropherogram from a 
358-bp M1/M2 primer second PCR amplicon, sequenced with M2 primer, showing the underlined common 
relapsing fever borrelial 16S rRNA gene sequence complex CTTTCGA immediately downstream of the M1 
primer binding site. The unique bases for B. miyamotoi in this segment were not marked (see Figure 1, 
Sequence #9).  This sample was from a tick collected in Portumna, Galway County, Ireland. The underlined 
GTC sequence at position 11-13, in contrast to the sequence GTT at this position in Sequence #9, Figure 1, 
indicates that this strain of B. miyamotoi found in a tick in Ireland may be identical to Borrelia sp. LB-W100 
often isolated in Europe (Sequence ID: AF529085)                                   
 
Figure S7  In contrast to the B. miyamotoi isolated from an Irish tick with a sequence shown in Figure 
S6, an isolate of B. miyamotoi from a sample of the serum repository panel accepted by the CDC as 
reference sera from “proven” Lyme disease patients was found to belong to Borrelia miyamotoi LB-2001 
(Sequence ID: CP006647). The sequence of the M1/M2 primer second PCR amplicon with M1 sequencing 
primer was reported to the CDC on November 21, 2013 as follows. (Note the sequence AAC underlined 
in position 169-171 is the reverse complement of GTT). 
 
Figure S8. Sequence of the M1/M2 primer second PCR amplicon of the CDC serum sample (Figure 
S7) with M2 sequencing primer, showing a reverse complementary sequence of a strain of B. 
miyamotoi LB 2001 infecting a patient who was diagnosed as having Lyme disease (Note the 
underlined sequence GTT at position 22-24 compared to the underlined sequence GTC at position 
11-13 in Figure S6 for the B. miyamotoi detected in a tick collected in Ireland).        
 
Figure S9. Blood sample from a patient with persistent co-infection by B. burgdorferi and B. miyamotoi. 
This was M2 primer sequencing of an M1/M2 primer second PCR amplicon. The black arrows indicate 3 
superimposed base calling double peaks, C/T at position 211, G/A at 220 and T/C at 267 before the 
frameshift indels  following peak 271 due to a one-nucleotide gap of the B. burgdorferi sequence in this 
segment (see Figure 1, compare Sequence #1 and Sequence #9), representing a feature characteristic of two 
overlapped sequences derived from these two borreliae. The underlined sequence A/GTT at position 94-96 
indicates that the strain of B. miyamotoi in this mixed infection was B. miyamotoi LB 2001, not Borrelia sp. 
LB-W100 (see Figure S6, underlined sequence GTC).   
                                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S10. M2 primer sequencing segment of an M1/M2 primer second PCR amplicon derived from 
the DNA extract of a tick removed from the skin bite of a person living in Connecticut, U.S.A., showing a 
mixed infection by B. burgdorferi and B. miyamotoi with two overlapped sequences, similar to that illustrated 
in Figure S9. Again, the B. miyamotoi in the mixture was strain LB 2001, not Borrelia sp. LB-W100 as shown 
in the underlined sequence G/ATT at position 75-77. Note frameshift indels sequence after peak 252.  
 
 
 
 
Figure S11. M2 primer 16S rRNA gene sequencing of the M1/M2 primer second PCR products of the 
DNA extract from a pure culture of B. coriaceae (ATCC 43381). Note the underlined common relapsing fever 
borrelial 16S rRNA gene sequence complex CTTTCGA at position 184-190 immediately downstream of the 
M1 primer site and the unique underlined base “T” at position 57 for B. coriaceae (see Figure 1, Sequence 
#11). 
 
 
 
 
 
Figure S12. Segment of a 282-base 16S rRNA gene sequence defined by the Bg5 and Bg6 primers and 
generated with a Bg6 sequencing primer showing DNA of B. burgdorferi sensu lato from a tick collected in 
Connecticut. The sequence is that of a strain of B. burgdorferi, not B. garinii because of its unique underlined 
base “G” at position 63 (see Figure 2, Sequence #1) 
 
  
 
Figure S13. Segment of a 282-base 16S rRNA gene sequence defined by the Bg5 and Bg6 primers and 
generated with a Bg6 sequencing primer on the DNA extract of a tick collected in Portumna, Galway 
County, Ireland. The underlined base “T” at position 63 indicates that it was a strain of B. garinii (compare 
this base “T” with the underlined base “G” at position 63 in Figure S12 and see Figure 2, Sequences #1 and 
#3).  Single nucleotide polymorphisms in this 282 -base sequence also indicated that this was a B. garinii 
Strain BgVir (Sequence ID: CP003151), not B. garinii Strain T25 (Sequence ID: AB035388), and not B. garinii 
Strain Bernie (Sequence ID: D89900). 
 
Figure S14. As illustrated in the five electropherograms pasted below, Sanger sequencing of the second 
(same-nested) PCR products of the NYS Lyme proficiency test samples #14, #15, #17, #18 and #20 (see Figure 
3, lanes 14, 15, 17, 18 and 20) showed that the PCR products derived from samples NYS-15 and NYS-20 
both consisted of DNA typical  of a segment of B. burgdorferi sensu lato 16S rRNA gene sequence (Figure 
1). The PCR product bands observed in lanes 14, 17 and 18 resulted from non-target PCR amplification in 
the absence of a target template. The M2 sequencing primer was not able to generate one DNA sequence 
on sample NYS-14 for the computer program to perform the function of base calling although the non-
target PCR products generated on this sample migrated at roughly the same speed as the borrelia DNA to 
form a band of similar size at gel electrophoresis. The PCR products shown in lanes 17 and 18 were those 
of human genomic DNA as a result of amplification of non-target DNA with partial complementary 
sequence match with the PCR primers.   Note: On NYS-17 sample sequence the M1 PCR primer annealed 
to a human genomic DNA segment with 11 matched nucleotides (underlined). On NYS-18 sample sequence 
the M1 PCR primer annealed to a human genomic DNA segment at position 152-160 (9 nucleotides 
underlined).  
 
 
 
  
 
 
Submission of NYS-17 sequence to the GenBank for BLAST alignment analysis confirmed that it is a 
segment of human genomic DNA within the “Homo sapiens chromosome 20” (see GenBank report below) 
which was amplified by the M1 and M2 primers in a human blood sample negative for borrelia DNA. 
 
 
 
 
 
 
 
 
Submission of NYS-18 sequence to the GenBank for BLAST alignment analysis confirmed that it is a 
segment of human genomic DNA within the “Homo sapiens chromosome 8” (see GenBank report below) 
which was amplified by the M1 and M2 primers in a human blood sample negative for borrelia DNA.  
  
Figure S15.  Segment of a 282 bp B. miyamotoi 16S rRNA gene sequence defined by Bg5 and Bg6 primers 
(see Figure 2). The sequencing primer was Bg6. The sample DNA used to initiate the PCR was from the 
same NH4OH digestate of the tick collected in Portumna, Galway County, Ireland which was used to 
generate the DNA sequence presented in Figure S6. Comparing the sequence presented in Figure S6 and 
the sequence presented in Figure S15 showed that the PCR products amplified by the M1/M2 primers 
(Figure S6) were generated by a single target template, and were free of ambiguous base-calling peaks on 
the sequencing electropherogram.  However, when the PCR products generated on the same sample by a 
pair of Bg5/Bg6 primers were sequenced, numerous ambiguous base-calling peaks appeared on the 
electropherogram and the sequences “TT” at positions 4-6, 17-19 and 25-27 were misread as “TTT” by the 
computer due to interference by non-target DNA PCR products.   
                                                
 
 
 
 
 
 
 
Figure S16. Segment of a 282 bp B. coriaceae 16S rRNA gene sequence defined by Bg5 and Bg6 primers 
generated in the same experiment described above (for Figure S15) as positive control, showing a unique 
base “C” at position 33 (see Figure 2, Sequence #11). Note the almost identical ambiguous base-calling peaks 
on Figure S16 as those shown in the Figure S15 electropherogram and the same sequences “TT” at positions 
4-6, 17-19 and 25-27 being misread as “TTT” by the computer due to interference by non-target DNA PCR 
amplification. Since the nested PCR products used to generate the sequence in Figure S16 were those 
amplified from the DNA extract of a pure culture of B. coriaceae with a highly conserved relapsing fever 
borrelia 16S rRNA gene, the almost identical non-target DNA PCR products causing the ambiguous base-
calling peaks in the electropherograms in both Figures S15 and S16 must have resulted from amplification 
of certain relapsing fever borrelia genomic DNA fragments by the Bg5 and Bg6 primers. As shown in 
Figures S12 and S13, the Bg5/Bg6 heminested PCR primer pair did not generate similar interfering non-
target DNA products from the DNA extracts of B. burgdorferi sensu lato species.         
 
